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Mutations in the gene encoding the MECP2 underlies Rett syndrome, a
neurodevelopmental disorder in young females. Although reduced pain sensitivity in
Rett syndrome patients and in partial MeCP2 deficient mice had been reported, these
previous studies focused predominantly on motor impairments. Therefore, it is still
unknown how MeCP2 is involved in these sensory defects. In addition, the human
disease manifestations where males with mutations in MECP2 gene normally do not
survive and females show typical neurological symptoms only after 18 months of age,
is profoundly different in MeCP2-deficient mouse where all animals survived, and males
but not females displayed Rett syndrome phenotypes at an early age. Thus, the mecp2-
deficient zebrafish serves as an additional animal model to aid in deciphering the role
and mechanisms of Mecp2 in neurodevelopment. Here, we used two independent
methods of silencing expression of Mecp2 in zebrafish to uncover a novel role of
Mecp2 in trigeminal ganglion sensory neurons during the embryonic development.
mecp2-null mutation and morpholino-mediated silencing of Mecp2 in the zebrafish
embryos resulted in defects in peripheral innervation of trigeminal sensory neurons
and consequently affecting the sensory function. These defects were demonstrated
to be dependent on the expression of Sema5b and Robo2. The expression of both
proteins together could better overcome the defects caused by Mecp2 deficiency as
compared to the expression of either Sema5b or Robo2 alone. Sema5b and Robo2
were downregulated upon Mecp2 silencing or in mecp2-null embryos, and Chromatin
immunoprecipitation (ChIP) assay using antibody against Mecp2 was able to pull down
specific regions of both Sema5b and Robo2 promoters, showing interaction between
Mecp2 and the promoters of both genes. In addition, cell-specific expression of Mecp2
can overcome the innervation and sensory response defects in Mecp2 morphants
indicating that these MeCP2-mediated defects are cell-autonomous. The sensory
deficits caused by Mecp2 deficiency mirror the diminished sensory response observed
in Rett syndrome patients. This suggests that zebrafish could be an unconventional but
useful model for this disorder manifesting defects that are not easily studied in full using
rodent models.
Keywords: Mecp2, trigeminal ganglion, sensory functions, Rett syndrome, neurodevelopmental disorder, axon
guidance cues, Robo2, Sema5b
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INTRODUCTION
Mutations in the gene encoding the Methyl-CpG binding protein
2 (MECP2) underlies Rett syndrome, a neurodevelopmental
disorder presented with mental retardation, autistic behavior,
compromised sensory sensations and loss of previously acquired
cognitive milestones, including purposeful hand use and
expressive language, in young females. Other clinical features of
Rett syndrome include impairment of sleep pattern, breathing
disturbance when awake, peripheral vasomotor disturbance,
autonomic dysfunction (cold, blue extremities), dystonia,
progressive scoliosis and diminished response to pain (Hagberg
et al., 1983; Amir et al., 1999; Armstrong, 2005; Downs et al.,
2010; Neul et al., 2010). It has been documented that about
90% of all Rett syndrome cases resulted from mutations in the
X-linked MECP2 (Amir et al., 1999; Shahbazian and Zoghbi,
2001; Armstrong, 2005; Bienvenu and Chelly, 2006).
MeCP2 is a multifunctional protein that was ﬁrst identiﬁed by
its ability to bind to methylated DNA (Lewis et al., 1992; Bird,
2008; Guy et al., 2011). Earlier studies on MeCP2 demonstrated
its role as transcriptional repressor for a selected set of target
genes (Nan et al., 1997; Chandler et al., 1999). Subsequent studies
showed that MeCP2 may be involved in both transcriptional
repression or activation, depending on the molecular context
(Chahrour et al., 2008; Ben-Shachar et al., 2009; Guy et al.,
2011). In addition, MeCP2 was shown to interact with the
RNA-binding protein Y box-binding protein 1 and regulates the
splicing of reporter minigenes, and is possibly responsible for
the aberrant alternative splicing patterns in a mouse model of
Rett syndrome (Young et al., 2005). Thus, mutations in MECP2
are expected to alter expression of its downstream target genes
with the consequences of impaired neuronal development and
function.
Alterations in MeCP2 expression have been detected in
autism spectrum disorders as well as in non-syndromic
mental retardations (Chahrour and Zoghbi, 2007). MeCP2 is
ubiquitously expressed, but its critical function in the mammalian
brain is suggested by the abundant expression of MeCP2 in the
CNS (Skene et al., 2010). Therefore, most of the current studies
on Rett syndrome and MeCP2 are focused on the development
of neurons in the developing or adult CNS (Ma et al., 2015; Zhao
et al., 2015). Moreover, the panembryonic Mecp2 gene knockout
or the brain-speciﬁc gene knockout in mice showed similar
neurological phenotypes (Chen et al., 2001; Guy et al., 2001).
These studies suggested a requirement for MeCP2 in the normal
development of the nervous system. The importance of MeCP2
in embryonic development as well as postnatal physiological
processes underlies the majority of disease etiologies associated
with Rett syndrome. Although reduced pain sensitivity in Rett
syndrome patients and reduced pain recognition in partial
MeCP2 deﬁcient mice have been reported (Samaco et al., 2008;
Downs et al., 2010), it is still unknown howMeCP2 is involved in
these sensory responses.
Like many X-linked disorders, Rett syndrome patients
displayed mosaic expression of mutant and normal MeCP2
protein in diﬀerent cell types, resulting in signiﬁcant variations
in phenotypes and clinical severity (Shahbazian and Zoghbi,
2001; Christodoulou and Weaving, 2003; Skene et al., 2010).
Moreover, not much is known with regards to the diﬀerences
of the various MeCP2 protein isoforms and mutations during
early development as well as in disease pathology. The MECP2
gene is also present in non-mammalian vertebrates, including
the zebraﬁsh Danio rerio (Coverdale et al., 2004) and mecp2-
null zebraﬁsh also shows altered motor behaviors (Pietri
et al., 2013). The mecp2-null zebraﬁsh model enables the
screening for genes involved in early development and will
aid in deciphering the role and mechanisms of Mecp2 in
vertebrate neurodevelopment. Using both mecp2-null mutants
andmecp2morpholino-mediated knockdown approach, we have
identiﬁed an important role for and also established underlying
mechanisms of Mecp2 function in vertebrate neurodevelopment.
Speciﬁcally, we found Mecp2 regulating projections of sensory
neurons and sensory responses, at least in part, through directly
activating transcription of speciﬁc axon guidance cues, Sema5b
and Robo2.
RESULTS
Mecp2 Plays a Role in Embryonic
Development of Zebrafish
In situ-hybridization showed that mecp2 in the zebraﬁsh
is ubiquitously expressed in the central nervous system
(CNS), with the highest level of expression found in the
forebrain (Figure 1A). We next compared genomic organization
of mammalian (human) MECP2 and zebraﬁsh mecp2 gene
(Figure 1B). Zebraﬁsh mecp2 contains three exons while
human MECP2 contains four exons. Although zebraﬁsh mecp2
does not have exon 2 of human MECP2, it also contains
two main domains critical for its functions. These are a
methyl-cytosine binding domain (MBD) and a transcriptional
repression domain (TRD) that shares 85.9 and 54% identity
respectively with mammalian species (Coverdale et al., 2004).
mecp2-null mutants (Q63∗) was a nonsense mutation generated
through N-ethyl-N-nitrosourea (ENU)-mutagenesis. This Q63∗
position is located directly before the MBD domain leading
to a loss of function (Pietri et al., 2013). Since there are
no available antibodies against zebraﬁsh Mecp2, we designed
MO oligonucleotide corresponding to the sequence of the
splice acceptor site at the intron 1-exon 2 border on zebraﬁsh
mecp2. This is so that the eﬃciency and speciﬁcity of splicing
blocker MO can be determined by RT-PCR (Figures 1C,D).
Using two sets of primers (a forward primer on exon 1
and a reverse primer on exon 2 or exon 3) (Figure 1B), a
deletion of the 372 bp fragment in the exon 2 was detected
in morphant pre-mRNA resulting in absence (primer set 1 –
Figure 1C) or shorter PCR product (primer set 2 –Figure 1D).
MO corresponding to the sequence of the ATG translation
initiation site was also tested and the morphants showed similar
phenotypes as those injected with splicing blocker MO (data not
shown).
MeCP2 was previously shown to regulate neurite growth
and axon targeting in the hippocampus, motor cortex and
olfactory system of the mouse (Matarazzo et al., 2004; Belichenko
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FIGURE 1 | Knocking down Mecp2 in zebrafish. Mecp2 is ubiquitously
expressed throughout the CNS at 24 hpf (A). The embryos are displayed as
whole mounts, dorsal view (F- forebrain, M - midbrain and H-hindbrain, S -
spinal cord, E- eye) Scale bar = 60 μm. Schematic diagram shows gene
structure of the zebrafish mecp2 and the mammalian (human or mouse)
MeCP2α isoform (B). The zebrafish mecp2 gene consists of 3 exons with the
main domains highlighted in red (Methyl-CpG-binding domain) and green
(transcriptional repressor domain). The splice blocking morpholino targets the
intron 1/exon 2 boundary on mecp2 pre-mRNA. Arrows below Zebrafish
mecp2 gene show the positions where the forward and reverse primers were
targeted [primer set 1 with black arrows for experiment in (C) and primer set 2
with gray arrows for (D)]. The specificity of morpholino was determined by
RT-PCR (B,C). Representative gel images showing normal splicing of mecp2
as a band of 400 bp with actin (206 bp) as the control (C). Representative gel
image showing normal splicing of mecp2 in WT (1455 bp) or blocked splicing
band (exon skipping) (1086 bp) in mecp2 spliced MO injected embryos (D).
Representative images showing gross morphological changes in TG neurons
projections induced by mecp2 MO during development of zebrafish at 24 hpf
(E). Scale bar = 50 μm.
et al., 2009; Degano et al., 2009; Palmer et al., 2012). Thus, we
ﬁrst examined gross axonal projections using an axon marker,
acetylated tubulin (AcTub) at 24 h post fertilization (hpf). The
projections of the sensory neurons of the trigeminal ganglion
(TG) are among the earliest detected with anti-AcTub antibody
(Metcalfe et al., 1990). Uninjected WT embryos or embryos
injected with control or mecp2 MO at one-cell stage were
examined at 24 hpf for gross morphologies of their projections
from TG neurons (Figure 1D). Uninjected WT and control
MO-injected embryos exhibited similar gross morphology of
TG neurons and their projections. However, Mecp2 morphants
showed signiﬁcantly less peripheral projections from TG
(Figure 1E).
Mecp2 Knockdown Decreases
Projections from Sensory Neurons
Visibly less arborizations of peripheral projections from TG
were observed in Mecp2 morphants (Figure 1E). Thus, we next
quantify this defect by measuring the total projection length
in each embryo (as mean projection length in μm). Knocking
down of Mecp2 indeed inhibits growth and branching of the
peripheral axons, resulting on average a 45% decrease in total
length of peripheral axon projections as compared to controls.
A potential caveat in interpreting these results is that some MOs
can activate p53, thus causing non-speciﬁc neural defects (Robu
et al., 2007; Eisen and Smith, 2008). We therefore routinely
used p53 MO to relieve possible non-speciﬁc neural cell death
caused by toxicity eﬀects of MOs (Robu et al., 2007). We found
that embryos injected with mecp2 MO together with p53 MO
showed similar phenotypes in sensory neurons compared to
those injected withmecp2MO alone. To further ensure that these
phenotypes are not due to oﬀ-target eﬀects, we performed rescue
experiments by co-injection with mecp2 mRNA (Figures 2A,B).
We found phenotypes of Mecp2 morphants could be reversed
by co-injection with mecp2mRNA (Figures 2A,B). These results
suggest that Mecp2 plays a key role in axonal development in
zebraﬁsh sensory neurons.
To further verify the speciﬁcity of these morpholino-mediated
phenotypes, we also examined neurite projections in mecp2-
null mutants (Q63∗). These mecp2-null ﬁsh exhibit clear altered
behavioral alterations such as spontaneous and sensory-evoked
motor anomalies, as well as defective thigmotaxis and have a
relatively shorter lifespan than WT ﬁsh (Pietri et al., 2013).
Thesemecp2-null embryos also show defect in TG projections as
compared to WT control embryos, with about 15–20% decrease
in the mean dendrite length of TG neurons as compared to WT
control embryos (Figures 2C,D). Since thismecp2-null mutant is
generated from a mutation that putatively truncated the protein
at amino acid position 63, the truncated Mecp2 protein may still
have residual Mecp2 activity. Thus, we next carried out titration
experiments by injecting two diﬀerent doses (500 and 800 μM)
ofmecp2MO inWT-CTR or Q63∗ mutant embryos (Figure 2E).
This is to further rule out any oﬀ-target eﬀects from mecp2 MO
and to determine if this truncated Mecp2 protein in mecp2-null
embryos is still functional in promoting TG projections. WT-
CTR embryos showedmore severe defects in the mean projection
length upon injection with higher concentration of Mecp2 MO.
However, the increasing concentrations of mecp2 MO did not
cause further projection defects in Q63∗ mutants (Figure 2E),
suggesting that there is no residual Mecp2 activity in mecp2-null
mutant embryos, at least in these sensory neuron projections at
the time point examined. These data obtained by titrating the
Mecp2 MO in a null genetic background as compared to control
embryos, further conﬁrmed the speciﬁcity of ourmecp2MO.
Cell Autonomous Effect of Mecp2 on
Sensory Neurons During Embryonic
Development
Since a high rate of transient apoptosis during neurodevelopment
is crucial for normal neurodevelopment in zebraﬁsh (Cole
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FIGURE 2 | Knockdown of Mecp2 affects the axonal projection of
trigeminal ganglion (TG) cells. Structure of peripheral dendritic projection
and nerve pathways revealed by axon marker, acetylated tubulin (green), a
general nucleus marker, DAPI (blue) and a neuronal marker, islet1 (red) at 24
hpf (A). Representative images showing peripheral axonal projections from
sensory neurons of TG in wild-type controls (WT, top panel), Mecp2
morphants (second panel from top), Mecp2 morphants rescued by coinjecting
mRNA of Mecp2 (third panel from top) and Mecp2 morphants coinjected with
p53 MO (lower panel) (A). Quantitative analysis of total peripheral projections
of trigeminal sensory neurons, with graph presenting total length of peripheral
projections from trigeminal ganglia per zebrafish (B) N > 10. Representative
images showing peripheral axonal projections from sensory neurons of TG in
wild-type controls (WT, top panel) and mecp2Q63
∗/Q63∗ mutants (Mecp2-Q63,
bottom panel) (C). Graph showing quantitative analysis of peripheral
projections (total length) from trigeminal ganglia per zebrafish in wild-type
controls and mecp2Q63
∗/Q63∗ mutants (D). Graph showing total neurite length
of controls (CTR) and mecp2Q63
∗/Q63∗ mutants (Q63) injected with either 500
or 800 μM of mecp2 MO (E). Scale bar = 50 μm. Each individual dot on
graph (E) represents individual embryos. N = 30 in each group. (∗P < 0.05,
∗∗P < 0.01, ∗∗∗P < 0.0001, student t-test for (D) and one-way ANOVA with
Bonferroni’s post hoc test for (B,E)].
and Ross, 2001), we examined the morphants using terminal
deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end
labeling (TUNEL) labeling at 16 and 24 hpf. Knocking down
FIGURE 3 | Cell autonomous effect of Mecp2 on sensory neurons
during embryonic development. Embryos were injected with mecp2 MO
and labeled with TUNEL. Antibody against HuC was used to label cell bodies
in TG. Representative images showing TUNEL labeling in TG in wild-type
controls (WT, left panel), Mecp2 morphants (right panel) (Blue – DAPI, Green –
HuC and Red – TUNEL) (A). Quantitative analysis of TUNEL-labeled cells
(indicative of apoptosis) at 16 and 24 hpf were presented in graphs showing
total number of TUNEL positive cells per 12 mm × 12 mm in the head (B).
Representative images showing peripheral axonal projections from sensory
neurons of TG in Mecp2 morphants rescued by coinjection with huC-gfp
control plasmids (left panel) or huC-mecp2 plasmids (right panel) (C).
Quantitative analysis of total peripheral projections of trigeminal sensory
neurons, with graphs presenting total length of peripheral projections from
trigeminal ganglia per zebrafish (D). N > 10 in each group. Scale bar = 50 μm
(∗∗∗P < 0.0001, one-way ANOVA with Bonferroni’s post hoc test).
Mecp2 increases the level of apoptosis at 16 and 24 hpf as
compared to control (Figures 3A,B). There were an average of
7.5 and 14.0 TUNEL-positive cells per area of 12 mm× 12 mm in
the head of morphants at 16 and 24 hpf respectively, as compared
to the 2.0–4.0 TUNEL-positive cells in control embryos at both
time points (Figures 3A,B). However, very few of the TG neurons
were TUNEL-positive as shown by a low number of TUNEL-
positive cells colocalized with a pan neuronal marker, HuC that
labels diﬀerentiating neural cells (Figure 3A). The expression
pattern of HuC in the early diﬀerentiating neurons was previously
described (Park et al., 2000; Sato et al., 2006). HuC highlighted
the ﬁrst diﬀerentiated trigeminal neurons at 11 hpf. By 24 hpf,
the TG has an average of 37 ± 3 neurons, and all these neurons
express HuC. Other proteins such as Islet1, Trpa1b and P2x3b
are also expressed in the TG, but are only expressed in diﬀerent
subpopulations of the trigeminal sensory neurons (Caron et al.,
2008). Therefore, HuC was used as a marker to identify whether
speciﬁc genes of interest are localized in all or only a subset
of trigeminal sensory neurons (Pan et al., 2012). These studies
indicated HuC as an ideal promoter to identify neurons in
the TG.
To rule out non-cell-autonomous eﬀect on sensory neurons
from this general increase in apoptosis of the surrounding
cells, we generated a construct with HuC promoter driving the
expression of Mecp2 in neurons only. Since GFP intensity varies
in diﬀerent cells and low GFP intensity in most projections
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does not allow proper and unbiased tracings, we quantiﬁed total
length and number of projections using acetylated tubulin as
a marker (Figures 3C,D). Expression of huC-mecp2 in Mecp2
morphants was able to rescue reduction in axonal projections
in TG neurons (Figures 3C,D). The rescue is not as eﬃcient
as compared to that of mecp2 mRNA, because not all TG cells
express Mecp2 under the HuC promoter. Nonetheless, the rescue
by huC-mecp2 is signiﬁcant and huC-gfp control does not have
any eﬀect on axonal projections in Mecp2 morphants. Taken
together, these results conﬁrm that the morphant phenotype
is not caused by an increase in apoptotic cells in the vicinity
of TG. Our data suggest that defects in sensory neurons
resulting from Mecp2 knockdown represent a cell-autonomous
eﬀect.
Mecp2 Regulates Transcriptional
Activation of Axon Guidance Cues
The known function of MeCP2 mainly involves its binding to
methylated-CpG islands as well as activating and suppressing
transcription. We therefore sought to examine the role of
Mecp2 in regulating gene expression in zebraﬁsh. Expression
proﬁling was undertaken using a 135K-zebraﬁsh gene expression
array (∼38,000 known transcripts), comparing the transcriptome
of wild-type controls with Mecp2 morphants. A total of
1123 genes had a minimum of 2-fold change over control
(p < 0.05), but only 1005 of which had a mammalian (human or
mouse) ortholog (http://www.ncbi.nlm.nih.gov/geo/ – accession
number GSE71173). Out of these 1005 genes, 607 were down-
regulated and 398 were up-regulated (minimum twofold change;
signiﬁcance was established at p < 0.05) in Mecp2 morphants,
and 118 genes (43 down-regulated and 75 up-regulated) are
without human orthologs (Figure 4A). These results strongly
suggest that knocking down Mecp2 could either activate or
repress transcription. Functional analysis of these 1123 genes in
silico using the program Database for Annotation, Visualization
and Integrated Discovery (DAVID) yield the following. Mecp2-
regulated genes in zebraﬁsh appear to function in diverse
cellular processes (Figures 4B,C). Many of the up-regulated
genes had roles in proliferation, cell communication and
metabolism. By contrast, many of the down-regulated genes
had functions related to neuronal development, including
neurogenesis, neuronal projection morphogenesis, cell migration
and synaptogenesis (Figures 4B,C). Since Mecp2 knockdown
resulted in projection defects in sensory neurons, we searched
for genes with axon guidance functions in our microarray that
can potentially be involved in Mecp2-mediated eﬀects. sema3f,
sema5b and robo2 were found in functional clusters involved in
mammalian brain and nervous system development, speciﬁcally
in neuronal projection morphogenesis, and they were strongly
down-regulated by knocking down Mecp2.
Non-quantitative and quantitative RT-PCR validated that
mRNA levels of sema3f, sema5b and robo2 were indeed
reduced in Mecp2 morphants (Figures 5A,B). Our results
suggest that Mecp2 plays an important role in the expression
of these axon guidance cues. To determine if these genes
are also downregulated in mecp2-null mutants, we examined
FIGURE 4 | Mecp2 morphants showed decreased expression of axon
guidance cues. Schematic diagram showing the number of genes that are
upregulated or downregulated in Mecp2 deficient embryos (A). Out of the
1005 genes that were found to have putative mammalian orthologs, 607 were
downregulated and 398 were upregulated (minimum twofold change;
significance was established at p < 0.05) in Mecp2 morphants (A). Dot plots
showing downregulated (B) and upregulated (C) genes. Each dot represent a
single gene with at least twofold increased or decreased in expression
presented as log values (base10) on y-axis. Relative fold change of
downregulated genes, sema3f (0.352568), sema5b (0.523226) and robo2
(0.537693) were highlighted as colored dots (red, orange, and black
respectively) in their respective functional groups.
mRNA expression of sema3f, sema5b and robo2 in control
and mecp2-null embryos (Figure 5C). There are modest
but signiﬁcant changes in sema3f, sema5b and robo2 mRNA
expression level in mecp2-null mutant as compared to WT
control embryos. The modest change in the mRNA expression
in mecp2-null mutants likely contributed to the subtle defects
in TG projections in mecp2-null mutants. Whereas the bigger
change in expression of these axon guidance cues in mecp2
MO-mediated knockdown embryos contributed to the more
severe defects. Moreover, injection ofmecp2MO intomecp2-null
embryos did not aﬀect mRNA levels of sema3f, sema5b or robo2.
These results conﬁrmed that there are possibly compensatory
eﬀects inmecp2-null mutants as compared tomecp2MO injected
embryos.
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FIGURE 5 | Sema5b and Robo2 rescue Mecp2-induced defects in
axonal projections in TG. Representative gel images showing sema3f,
sema5b and robo2 mRNA levels regulated by Mecp2 (A). Graph presenting
quantitative RT-PCR of the three above mentioned genes in WT or Mecp2 MO
injected embryos (B). Graph showing expression of sema3f, sema5b and
robo2 mRNA in CTR and mecp2Q63
∗/Q63∗ mutants using RT-PCR (C). Data
are presented as fold expression of each gene normalized with housekeeping
gene, beta-actin to value 1. (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, two-way
ANOVA with Bonferroni’s post hoc test). Sema5b and Robo2 rescue axonal
projection of TG cells. Representative images showing peripheral projections
of trigeminal sensory neurons in embryos injected with mecp2 MO together
with mRNA of Sema5b, Robo2 or both (D). Quantitative analysis of total
peripheral projections from trigeminal sensory neurons, with graph presenting
total length of peripheral projections from trigeminal ganglia per zebrafish (E)
(Blue – DAPI, Green – acetylated tubulin, Red – islet1). N > 10 in each group,
Scale bar = 50 μm.
Sema5b and Robo2 are Essential for
Mecp2-Mediated Defects of Axon
Projections
Although there are changes in expression levels of class 3
semaphorins and their receptors in Mecp2-null mice, neither
Sema3A or 3F has eﬀects on repulsion or neurite outgrowth
response ofMecp2-null olfactory axons (Degano et al., 2009). We
also did not observe signiﬁcant defects in embryos injected with
morpholino targeting sema3f (Data not shown). Therefore, to
further establish Robo2 and Sema5b-mediatedMecp2-dependent
neuronal projection morphogenesis, we asked if the defects seen
in Mecp2 morphants could be rescued by Robo2 and Sema5b.
We co-injected mRNAs of robo2 or sema5b or both together
with mecp2 MO. Our data showed that excess Robo2 or Sema5b
alone modestly rescued defects observed in Mecp2 morphants
(average of 70 and 67% of control, respectively as compared
to the 50% in Mecp2 KD group) (Figures 5D,E). Importantly,
coexpression of both Robo2 and Sema5b in Mecp2 morphants
showed more projections from TG neurons (average of 90% of
control) as compared to single gene rescue (Figures 5D,E). These
results suggest that Robo2 and Sema5b expression plays a role
in the neurodevelopmental phenotype associated with loss of
Mecp2.
Mecp2 Directly Regulates Transcription
of sema5b and robo2
Next, we investigated whether Mecp2 directly regulates Robo2
and Sema5b expression by interacting with their promoters. We
carried out conventional chromatin immunoprecipitation (ChIP)
assay on 24 hpf wild-type embryos injected withmecp2-gfp using
GFP antibody, followed by site-speciﬁc PCR analysis. Primers
were designed within 2000 bp region upstream of translational
start site of both sema5b and robo2 promoters. Our results
showed that speciﬁc regions on the promoters of these two
mentioned genes co-immunoprecipitated with Mecp2 in vivo,
suggesting that their transcription is directly subjected to Mecp2
regulation (Figure 6A). Quantiﬁcation of PCR products showed
weak binding of Mecp2 to the promoter of sema5b at P4 (within –
1824 to −1723) and relatively strong binding at P1, P2, and P3
(within −155 to −57, −792 to −681, and −1310 to −1177)
regions (Figures 6A,C). On the other hand,Mecp2 binds strongly
to robo2 promoter at P1 and P4 regions (within −349 to −222
and −2045 to −1916), and does not bind or only binds very
weakly to P2 and P3 regions (−849 to −730 and −1374 to
−1236) (Figures 6A,B). These results suggest that Mecp2 is
likely to regulate transcription of Robo2 and Sema5b, through its
association with the promoters of both genes.
Mecp2-Mediated Defects of Axon
Projections Leads to Diminished Sensory
Response
Innervation of sensory neurons is essential for sensory functions,
which can be assessed by the ability of the embryo to respond
to tactile stimuli (Sagasti et al., 2005; Carmean and Ribera,
2010; Low et al., 2011). We found normal muscle striations
in Mecp2 deﬁcient embryos (Figure 7A), but these embryos
are less responsive to tactile stimuli as compared to controls
at 48 h after mecp2 MO injection (Figures 7B,C). WT control
embryos responded to head tactile stimuli within an average
of approximately 0.5 s upon tactile stimulation, whereas Mecp2
morphants took an average of 10.0 s to respond.
Importantly, HuC promoter speciﬁc expression of Mecp2
in TG neurons rescued the diminished sensory response in
Mecp2 morphants, reaﬃrming that the sensory behavioral
phenotype is a cell autonomous eﬀect resulting from a loss of
Mecp2 (Figure 7B). This diminished sensory response in Mecp2
morphants mirrors the sensory deﬁcit phenotypes observed
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FIGURE 6 | Mecp2 directly regulates transcription of robo2 and
sema5b genes. Chromatin immunoprecipitation (ChIP) analysis shows the
recruitment of Mecp2 to robo2 and sema5b promoters. Schematic diagram of
the 5′ promoter region of robo2 and sema5b. Short horizontal lines (red and
blue) labeled P1-4 indicate the relative positions of PCR products from the
respective sets of primers on both promoter regions (A). Representative gel
images (top panel – anti-GFP pulldown, middle panel – IgG control pulldown
and bottom panel – input) and quantitative analysis of ChIP assay performed
on 24 hpf wild-type embryos overexpressing Mecp2 protein (GFP-tagged
Mecp2) (B,C). Anti-GFP antibody pulled down specific robo2 and sema5b
promoter regions [strong binding as indicated by the PCR products (amplify
by their respective primers) in red, and very weak or no binding as indicated in
blue]. Graphs show fold difference ratio of ChIP with anti-GFP over ChIP with
IgG control normalized to value 1 (B,C). (∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001, two-way ANOVA with Bonferroni’s post hoc test).
in Rett patients, mouse models (Devarakonda et al., 2009;
Downs et al., 2010; Battaglia, 2011; Samaco et al., 2013) and
zebraﬁsh mecp2-null mutant (Pietri et al., 2013). To determine
if Robo2 and Sema5b directly play a role in Mecp2–mediated
sensory response, we coexpressed Robo2 and Sema5b in Mecp2
morphants (Figure 7B). This led to restoration of sensory
responses in Mecp2 morphants to levels comparable to WT
controls, indicating that Robo2 and Sema5b are downstream
proteins of Mecp2 that are responsible for mediating MeCP2-
dependent sensory responses (Figure 7C).
Taken together, our results show that Mecp2 plays a role in
embryonic development of zebraﬁsh. Mecp2 could function by
regulating the expression of genes acting during formation of
peripheral neurites by sensory TG neurons, which is essential for
sensory response (working model illustrated in Figure 7C).
DISCUSSION
Human males with mutations in MECP2 gene normally do not
survive, whereas females showed normal postnatal development
FIGURE 7 | Mecp2-mediated defects of axon projections leads to
diminished sensory response. Representative images showing arrays of
muscle fibers in WT control and Mecp2 morphants (KD) embryos
immunostained with monoclonal antibody A4.1025 (myosin) (A). In all panels,
anterior is to the left. (Blue-DAPI, red-myosin) Scale bar = 50 μm. Graphs
showing rates of response upon tactile stimuli (red arrow in C) from the six
experimental groups of WT and KD, including WT and KD coinjected with
various rescue constructs indicated on the graph, upon tactile stimuli applied
to the same region specified (B,C). Proposed model shows Mecp2 plays a
part in primary sensory projections through regulating transcription of Sema5b
and Robo2 (C). Each individual dot (B) represents individual embryos.
N > 30. (∗∗∗P < 0.0001, one-way ANOVA with Bonferroni’ post hoc test).
till 6–18 months of age, when typical neurological symptoms
started to appear (Amir et al., 1999; Armstrong, 2005). Male
rhesus and cynomolgous fetuses carryingMECP2mutations were
miscarried, while females did not show any obvious phenotypes
at least for the ﬁrst 4 months after birth during the study
period (Liu et al., 2014). The human disease manifestations
were profoundly diﬀerent from those seen in mouse Rett
syndrome models where all animals survived, and males but
not females displayed Rett syndrome phenotypes at an early age
(Guy et al., 2011). Despite showing clear behavioral alterations
during early development, mecp2Q63∗ mutant ﬁsh also survived
but has relatively shorter lifespan than WT ﬁsh (Pietri et al.,
2013). In addition, this mecp2Q63∗ mutant exhibits motor defects
compatible with motor phenotypes observed in Mecp2-null
mouse models and Rett syndrome patients. This mecp2Q63∗
mutant ﬁsh also showed delayed response to tactile stimulations
(Pietri et al., 2013) which is in agreement with defects exhibited
by Mecp2 morphants and MeCP2 deﬁciency in mice. Partial
MeCP2 deﬁciency in mice resulted in reduced pain recognition
in a hot plate assay (Samaco et al., 2008). Mecp2 knockdown in
zebraﬁsh resulted in retarded responses to tactile stimuli while
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exhibiting normal muscle striations as compared to controls
indicating that Mecp2-knockdown-induced defect in sensory
neuron projections is indeed responsible for the diminished
touch sensitivity observed.
The presumably null mecp2Q63∗ mutation is a nonsense
mutation generated using ENUmutagenesis approach, putatively
truncated the protein at position 63 and does not correspond
to any known human MECP2 mutations. In mice, the two
Mecp2 splice variants (Mecp2-e1 and Mecp2-e2) diﬀering only in
the ﬁrst 26 amino acids, show dramatically diﬀerent functions
such that forced expression of MeCP2-e2 but not MeCP2-e1
promotes cell death (Dastidar et al., 2012). Although the non-
lethality of this mutant ﬁsh could be that the truncated protein
still had functions essential for sensory neuronal projections in
zebraﬁsh, our data from titration experiments using diﬀerent
concentrations of mecp2 MO rule out this possibility. Injection
of mecp2 MO into WT-CTR but not these mecp2Q63
∗
mutants
aﬀected innervations of TG neurons and expression of the
axon guidance cues examined, conﬁrming speciﬁcity of our
mecp2 MO. Despite the absence of functional Mecp2, the
expression of axon guidance cues such as Sema5b and Robo2,
are only modestly but signiﬁcantly decreased in these mecp2Q63∗
mutants as compared to Mecp2 morphants. Thus, explaining
the milder TG projection phenotypes observed in mecp2Q63∗
mutants as compared to Mecp2 morphants and also suggesting
possible compensatory eﬀects in mecp2Q63∗ mutants. Possible
compensatory mechanisms include the presence of another
genetic alteration in the mecp2-null mutants that can suppress
eﬀects of the mecp2Q63
∗
mutation, functional compensation
through other proteins that have MBD and TRD domains
or Mecp2-independent positive feedback loop for regulating
Mecp2 target genes (Pietri et al., 2013). In fact, it has recently
been shown that genetic compensation in zebraﬁsh mutants
but not morphants is the key reason underlying the diﬀerence
in phenotypes between mutants and knockdowns (Rossi et al.,
2015).
Zebraﬁsh and human MeCP2 proteins share only about 43%
amino acid sequence identity (and 46.3% identity with Xenopus),
but the conserved domains are apparent (Coverdale et al., 2004)
and Mecp2 may thus serve similar functions in mammals and
ﬁsh. Zebraﬁsh Mecp2 protein is more similar to the mammalian
MeCP2α isoform than the MeCP2β in terms of N-terminus
and genomic organization (Coverdale et al., 2004). Studies
with mutant Mecp2 in Xenopus showed deﬁcits in binding of
Mecp2 to a corepressor complex (Stancheva et al., 2003). Mecp2
knockdown in zebraﬁsh reduces metabotropic-type glutamate
receptor 2 (mGluR2), which was also observed in Rett syndrome
patients (Blue et al., 1999). Some of the other Mecp2-regulated
genes that we found in zebraﬁsh, such as atxn1 and pax6, were
previously implicated in developmental delays in humans (Kim
et al., 2011; Celestino-Soper et al., 2012). Therefore, MeCP2-
regulated genes found in mammalians are likely to be involved
in similar processes in zebraﬁsh.
Functional categorization of all the Mecp2-regulated genes
on our array suggest that Mecp2 is involved in transcriptional
down-regulation of genes with roles in general cell maintenance,
but up-regulation of genes with roles in neuronal development,
speciﬁcally in neuronal diﬀerentiation, axon projections and
synaptogenesis. One possible explanation for MeCP2 acting as
transcription activator or repressor, is the binding of MeCP2
to either 5-hydroxymethylcytosine (5hmC) or 5-methylcytosine
(5mC) as shown in a recent study using mice. MeCP2 binding
to 5hmC can facilitate transcription in neural cell types, but
represses transcription when bound to 5mC containing DNA
(Mellén et al., 2012). However, the 5hmC and 5mC content in the
same genes vary between diﬀerent cell types. These variations can
therefore explain, or at least in part, for the very few overlaps in
MeCP2-dependent regulated genes found from diﬀerent studies,
especially from studies using diﬀerent cells and diﬀerent parts of
the mammalian brains (Guy et al., 2011). For example, one of
the most characterized target gene of MeCP2 – BDNF, does not
consistently appear to be regulated by MeCP2 in all the arrays
(Guy et al., 2011). Ratios of 5hmC/5mC in mouse Sema5b and
Robo2 (the two genes that we found transcriptionally activated by
Mecp2 in zebraﬁsh) are approximately 1 or much higher than 1
(ratio of 3) in purkinje cells (PCs) and specialized Bergmann glial
(BG) cell population, but is only about 0.2–0.4 in granule cells
(GCs) (Mellén et al., 2012). Therefore, suggesting that MeCP2
probably activates transcription of both Sema5b and Robo2 in PC
and BG but represses transcription of both genes in GC cells.
Our results show that Mecp2 knockdown causes defects
in projections from sensory neurons through activating
transcription of axon guidance cues represented by Sema5b
and Robo2. These defects in zebraﬁsh emulate sensory and
neuromotor deﬁcits seen in Rett syndrome patients (Samaco
et al., 2008; Devarakonda et al., 2009; Downs et al., 2010;
Battaglia, 2011). Although Rett syndrome patients have sensory
deﬁcits, this aspect of the disorder is still largely uncharacterized.
sema3f, sema5b and robo2 are genes that have roles in axon
projections and synaptogenesis and were signiﬁcantly down-
regulated in Mecp2 morphants (Figures 4 and 5). These
known axon repelling guidance cues appear to have axon
promoting functions in sensory neurons in zebraﬁsh (at
least for both Sema5b and Robo2). Previous studies in mice
showed guidance cues such as Slits (ligand for Robo receptor)
that typically act as axon repellents may also act to attract
some axons (such as DRG, trigeminal sensory neurons and
retinal axons inside the optic ﬁber layer) (Wang et al., 1999;
Nguyen Ba-Charvet et al., 2001; Jin et al., 2003; Ma and
Tessier-Lavigne, 2007). Semaphorins typically cause repulsion
and collapse of axons but could on the other hand promote
dendrite growth in hippocampal neurons (Ng et al., 2013).
Therefore, it could be possible that semaphorins can also
promote growth of some axons as observed for Slit/Robo.
Semaphorins are widely expressed in the developing nervous
system of mice, but there are no known roles of Sema5b
speciﬁcally. Previous studies in mouse models demonstrated
that semaphorins act as guidance cues for axon targeting,
cell migration, cell death or synapse formation during the
development of nervous system (Koncina et al., 2007). Severe
abnormality in peripheral nerve projections, which includes
trigeminal, facial, vagus, accessory and glossopharyngeal nerves
were observed in Sema3D knockout mouse (Taniguchi et al.,
1997).
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The Robo2 protein is highly conserved from ﬂy to humans,
and is known to function in developing nervous systems with
roles in axon guidance, synaptogenesis and cell migration (Yeo
et al., 2004; Campbell et al., 2007; López-Bendito et al., 2007;
Andrews et al., 2008; Pan et al., 2012). Mice deﬁcient in
Robo2 demonstrated obvious axon guidance errors, with a more
prominent eﬀect on mice deﬁcient in both Robo1 and Robo2
(López-Bendito et al., 2007). Like Robo2, Sema5b is also a ligand-
binding receptor. Besides its role as a guidance cue, little else
is known about its role in neuronal development. Interestingly,
Robo2 or Sema5b can both modestly rescue defective projections
from TG neurons in Mecp2 morphants. Although there are
no known expression studies on Sema5b in zebraﬁsh, Robo2
was found to be expressed in a subpopulation of HuC positive
cells of the TG in zebraﬁsh embryos at 24 hpf (Pan et al.,
2012). Therefore, partial rescue of the phenotype observed upon
expressing Robo2 alone could be because not all TG neurons
express Robo2. It is also possible that both Robo2 and Sema5b are
working together and are not able to achieve signiﬁcant rescue
eﬀect as an individual. Concurrent expression of both Robo2
and Sema5b can rescue this defect to approximately control
levels, suggesting that Robo2 and Sema5b plays important role
in mediating the eﬀects of Mecp2 in regulating projections of
sensory neurons. In contrast, although we found a decrease of
Sema3f expression in Mecp2 morphants, this decrease did not
translate to signiﬁcant defects, at least in the gross morphology
of zebraﬁsh embryos and also in projections of sensory neurons,
which is likely due to compensatory eﬀects from other class 3
semaphorins. Similar observation on mice was reported, where
abnormal levels of class 3 semaphorins and their receptors were
also observed in the olfactory system in Mecp2-null mice. But
neither Sema3A nor 3F elicited any diﬀerence in repulsion
or neurite outgrowth response of Mecp2-null olfactory axons
(Degano et al., 2009).
In summary, our data using mecp2-null mutants and
mecp2 MO-mediated knockdown approach show that Mecp2 is
important for peripheral innervation of sensory neurons in the
zebraﬁsh. Mecp2 knockdown in zebraﬁsh model recapitulates
sensory deﬁcits of Rett syndrome in humans. We also found
expression of well-known axon guidance cues such as Sema5b
and Robo2 positively regulated byMecp2 through its interactions
with speciﬁc regions on both promoters. These guidance cues
are essential for the Mecp2-dependent innervations from sensory
neurons and sensory response during embryonic development.
MATERIALS AND METHODS
Injection of Zebrafish
Wild-type zebraﬁsh of the AB strain were maintained under
standard conditions of ﬁsh husbandry. Freshly fertilized zebraﬁsh
eggs were injected with mRNA (100 ng/μl), plasmid DNA
(40 ng/μl), mecp2 morpholino (800 μM), robo2 morpholino
(200 μM) and sema5b morpholino (500 μM) at the one- to two-
cell stage in a volume of approximately 1 nl. Approximately 200
embryos were injected for each morpholinos or overexpresson
constructs. At least 30 embryos were analyzed for each
experimental group used per experiment. For experiments
using mecp2-null zebraﬁsh embryos, mecp2 splice blocking
morpholino was also injected into mecp2Q63∗/Q63∗ mutant
(mecp2-null) and its wild-type control embryos (WT-CTR)
(both in the Nacre background). The injected embryos
were cultured at 28◦C, and embryos were ﬁxed at speciﬁc
developmental stages for further analysis. Morpholinos were
purchased from GeneTools. Splice-blocking morpholino (5′-
CTCACCTCTGCTGACAACAAAATAA-3′) was selected for
knocking down Mecp2. This splice-blocking MO that allows
eﬃciency of MO to be determined through PCR, was used
for all the Mecp2 morphants shown here. The control
morpholino (5′-CCTCTTACCTCAGTTACAATTTATA-3′) and
p53 morpholino (5′-GCGCCATTGCTTTGCAAGAATTG-3′)
used were the scrambled sequence and a translational blocker
respectively from Gene Tools. All zebraﬁsh experiments were in
compliance and approved by the Singapore National Advisory
Committee on Laboratory Animal Research.
Cloning of Zebrafish mecp2, sema5b,
and robo2
cDNAs were synthesized from 24 hpf wild-type embryos using
cDNA synthesis kit (Invitrogen). These cDNA templates were
used for PCR ampliﬁcation of the full-length zebraﬁsh mecp2,
sema5b and robo2. The PCR products were cloned into TOPO
vector and subsequently sub-cloned into either pCS2-GFPxlt or
pSP64T expression vector for over expression studies and rescue
experiment. Full-length zebraﬁsh mecp2 was cloned into huC
promoter plasmid to induce speciﬁc expression in subsets of TG
neurons. GFP-expressing embryos were screened by ﬂuorescent
microscopy to determine for expression of injected constructs.
Only embryos that expressed GFP were used for all downstream
experiments and analysis.
Whole-Mount In Situ Hybridization
Puriﬁed plasmid was linearized by selected restriction enzymes
and used as templates for in vitro transcription using T7 or
SP6 RNA polymerase to generate Digoxigenin (DIG)-labeled
sense and antisense probes using DIG RNA labeling kit (Roche).
Whole-mount in situ hybridizations were performed following
routine protocols.
Antibody Staining and Terminal
Deoxynucleotidyl Transferase
(TdT)-Mediated dUTP Nick-End Labeling
(TUNEL) Assay
Whole-mount antibody staining on zebraﬁsh embryos was
performed according to standard protocols. The following
antibodies were used: rabbit anti-GFP (1:1000; Abcam),
monoclonal anti-acetylated tubulin (1:500; Sigma), monoclonal
anti-islet [1:100; The Developmental Studies Hybridoma Bank
(DSHB)], monoclonal antibody A4.1025 (skeletal muscle
myosin) (1:20; DSHB) and mouse anti-HuC/D (1:1000;
Invitrogen). For confocal microscopy, appropriate Alexa Fluor-
conjugated secondary antibodies (1:500; Molecular Probes) were
used for signal detection. Embryos were counterstained with
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4,6-diamidino-2-phenylindole (DAPI) to visualize cell nuclei
when required. For TUNEL assay, the embryos were made
more permeable by treating with proteinase K and 0.1% sodium
citrate prior to the standard protocol as recommended by the
manufacturer (Roche).
In Vitro Transcription of Capped mRNA
Plasmids encodingmecp2, sema5b and robo2were linearized, and
capped, full-length mRNA was transcribed from this template
using the mMessage mMachine Kit (Ambion). The mRNA was
injected into one- to two-cell stage embryos either alone or in
combination with a morpholino.
Zebrafish Gene Expression Microarray
Three independent pools of 24 hpf zebraﬁsh Mecp2 morphant
embryos were compared to three independent pools of 24
hpf control embryos. RNA extraction was done using RNeasy
mini kit (QIAGEN). The triplicate embryo pools made a
total of six hybridizations. cDNA synthesis, cDNA labeling,
microarray hybridization and washing were performed following
the manufacturer’s instructions (Roche NimbleGen). The 135K
NimbleGen array contains 135,000 probes targeting 38,489
transcripts derived from the Ensembl database built on the Zv7
assembly (37,157 zebraﬁsh genes identiﬁed). Array hybridization
was done using Maui Hybridization System and was scanned
using Axon GenePix 4000B Scanner. Data extraction and image
processing were performed using NimbleScan software v.2.6 and
the Robust Multichip Average (RMA) algorithm used to generate
gene expression values. The normalized data was subsequently
analyzed using ArrayStar. Threshold was set at twofold change
with a 95% conﬁdence interval by student’s t-test with Benjamini
Hochberg False Discovery Rate analysis.
Quantitative Real-Time PCR
One microgram of total RNA was used as starting
material. Reverse transcription was carried out with
Invitrogen’s SuperScript III First-Strand Synthesis kit using
oligo(dT) primers. Gene speciﬁc primers were used to
amplify sema3f (fw-5′ CAACCAGTACTGCCAAGACT
AC 3′; rv-5′ TCCTGGTGGTGTCTCCTATT 3′), sema5b
(fw-5′ CTGCTGTCTTTCCTGGTGTATG 3′; rv-5′
GTGGTGTTGCCCTTGTAGTT 3′) and robo2 (fw-5′
GACATACCTCCATCAGGGTTTAG 3′; rv-5′ GAAACTG
CAGCAGGAGAAGA 3′) by qPCR on a Biorad CFX96 RT PCT
using SYBR Select master mix (Invitrogen). A sample volume of
12 μl was used for all assays. All samples and standards were run
in triplicates. Three biological replicates were performed for each
set of data normalized using housekeeping gene beta-actin.
Chromatin Immunoprecipitation (ChIP)
Wild-type embryos were injected at one-cell stage with GFP-
tagged mecp2 RNA. They were harvested manually at 24
hpf, then dechorionated, deyolked and immediately crosslinked
to DNA by direct addition of formaldehyde at a ﬁnal
concentration of 1% for 10 min at room temperature.
Embryo tissues were lysed and sonicated (Sonics Vibra-
Cell) to produce DNA fragments that are between 300 and
800 bp. After sonication, ChIP assay was performed according
to Millipore protocol (Magna ChIP G Tissue Kit). Protein-
DNA complexes were immunoprecipitated overnight at 4◦C
in the presence of speciﬁc anti-GFP antibody (Abcam) or
control rabbit IgG (Santa Cruz Biotechnology). DNA was
puriﬁed and used directly for PCR of sema5b and robo2
promoters. Primers were designed within 2000 bp region
upstream of translational start site of sema5b promoter
(Primer 1: fw-5′ CTCTGCTGATCGTAAAGGTGTAT 3′; rv-5′
GTTAAAGAGGACAGACGGAGTG3′, Primer 2: fw-5′ TCCAG
CTCAGTTCAGTTCAAG 3′; rv-5′ TTGCGATTTCCAACATAT
ACATAGC 3′, Primer 3: fw-5′ GGGTTCAATTCCCTACAGT
CTT 3′; rv-5′ GGATGGATGGATTGATGGTTAGA 3′, Primer
4: fw-5′ TGTTCCACTTCTGGTCAGTTT3′; rv-5′ TCTGAGGA
GACCCAGCTTTA 3′) or robo2 promoter (Primer 1: fw-5′
GAGGATCGTAAGGTGCTTCTG3′; rv-5′ ACACCATCTCCTA
CTGTGTTTG 3′, Primer 2: fw-5′ ACACTGACATATTGGTGG
TCAT 3′; rv-5′ CAGCTTTCCGTGGTGTTTATTC 3′, Primer
3: fw-5′ CTTAGAGCTGACACTGGAAGATG 3′; rv-5′ TGG
GCGAACGGATAGATAGA 3′, Primer 4: fw-5′ TGCTGACA
CACCGCTAATC 3′; rv-5′ GAGGAATGCAAGGACCAATT
TC 3).
Behavior Studies
Wild-type embryos injected with either control morpholino
(800 μM), mecp2morpholino (800 μM), or in combination with
rescue constructs (∼40 ng for DNA and 100 ng for mRNA) were
allowed to develop to 48 hpf under normal growth conditions
before scoring was done. These embryos were dechorionated
manually and subjected to tactile stimuli at the head region.
Manual scoring was done by taking down the time required
by the embryo to produce a response upon stimulation applied
with the tip of a mounting needle. Zero seconds was recorded
for embryos that gave an immediate reaction to the tactile
stimuli.
Imaging, Analysis, and Figure
Preparation
Stained embryos were dissected from their yolk and mounted
in 70% glycerol. High-resolution images of embryos were
captured using a Zeiss LSM 710 confocal microscope (Carl
Zeiss Pte Ltd, Singapore). Low-resolution images were obtained
using a Zeiss SteREO Discovery V8 stereoscope equipped with
an Axiocam ICc3 color digital camera (Carl Zeiss Pte Ltd,
Singapore). For analysis of the neurite structure of TG cells,
three-dimensional (3-D) reconstructions of the processes of
all labeled cells were made from Z-series stacks of confocal
images. The projection images were semi-automatically traced
with NIH ImageJ using the NeuronJ plugin. The total length
of processes in each individual embryo were subsequently
measured and analyzed. All data were scrambled and only
decoded after analysis was done blinded. A total of >30
embryos from >3 individual experiments were analyzed
per group. Gel quantiﬁcation of DNA for ChIP PCR was
done using NIH ImageJ. Statistical signiﬁcance (P < 0.05)
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was assessed using student t-test, one-way or two-way ANOVA
with Bonferroni’ post hoc test, after normalization checked
using Shapiro–Wilk normality test. Figures were assembled using
Adobe Illustrator CS4.
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